Tandem Diabetes Care, Inc.

TNDM Healthcare Medical Devices

Tandem Diabetes Care, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.0 billion, up 7.93% from fiscal 2024.

Revenue
+13.8%
EPS
+67.7%
Free cash flow
−232.0%
Total debt
+94.9%

Quarter to September 2026, against a year earlier

17.08 0.91 −5.06%
Market cap
$1.3B
P/E
0.0×
Fwd P/E
−28.1×
Dividend yield
—
F-score
3/9
Altman Z
0.19
Beneish M
−3.10
Dividend safety
n/a

Tandem Diabetes Care, Inc. (TNDM) P/E ratio

Alert me on P/E ratio

Tandem Diabetes Care, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 1,368× (April 2022) — the current reading is the lowest in ten years.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 0.0× —
FY2024 0.0× —
FY2023 0.0× —
FY2022 0.0× —
FY2021 627× —
FY2020 0.0× —
FY2019 0.0× —
FY2018 0.0× —
FY2017 0.0× —
FY2016 0.0× —

Quarterly newest first

Period P/E ratio Change
Sep 2026 0.0× —
Jun 2026 0.0× —
Mar 2026 0.0× —
Dec 2025 0.0× —
43 more quarters

Against its own ten years

Low 0.0× High 1,368×
Ten-year median 0.0×
Current reading's percentile 92

P/E ratio against peers

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on TNDM